Loading company…
PORTAL BIOTECH develops cell engineering and delivery technologies, including red blood cell-based therapeutic vaccines.
Founded in 2023 and based in Shanghai, PORTAL BIOTECH develops a cell engineering platform, cell delivery technology, and red blood cell-based therapeutic vaccines. Founder Min Dong has nearly 20 years of biopharmaceutical industry experience. The company closed an angel funding round in August 2024 with Tian Rui Feng Nian Private Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in